Compliance Rate

Compliance Rate 100.0%
Compliant submissions 2
Incompliant submissions 0
Total trials 2

My Organizations' Clinical Trials

Showing 225 of 910 entries
View as:

Preventing the Loss of Muscle and Function in Hospitalized Older Adults

Phase: N/A Priority: Normal
NCT ID: NCT02566590 Org: User:
Start: 01/31/15 End: 12/31/16 Due: 12/31/17

Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04162873 Org: User:
Start: 11/27/19 End: 04/26/23 Due: 04/26/24

Massage for GAD: Neuroimaging and Clinical Correlates of Response

Phase: N/A Priority: Normal
NCT ID: NCT06506253 Org: User:
Start: 05/01/24 End: 08/31/25 Due: 08/31/26

MotionLoc Study, Femur Fractures

Phase: N/A Priority: Normal
NCT ID: NCT01612208 Org: User:
Start: 04/30/11 End: 01/31/13 Due: 01/31/14

Piloting GETCare: A Remote Goal-based Education and Skills Training Program for Caregivers Poststroke

Phase: N/A Priority: Normal
NCT ID: NCT05403021 Org: User:
Start: 08/31/20 End: 08/20/21 Due: 08/20/22

Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT05487300 Org: User:
Start: 05/11/22 End: 05/01/23 Due: 05/01/24

Ipilimumab and Dabrafenib in the 1st Line Tx of Unresectable Stage III/IV Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02200562 Org: User:
Start: 12/31/14 End: 01/20/17 Due: 01/20/18

Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial

Phase: N/A Priority: Normal
NCT ID: NCT04944836 Org: User:
Start: 03/09/23 End: 04/01/27 Due: 04/01/28

A Phase I/II Clinical Trial of Vidaza With Abraxane in Patients With Advanced/Metastatic Solid Tumors and Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00748553 Org: User:
Start: 09/30/08 End: 10/31/15 Due: 10/31/16

Stroke Rehabilitation, Functional Recovery, and Cost-effectiveness

Phase: N/A Priority: Normal
NCT ID: NCT04279977 Org: User:
Start: 01/27/20 End: 04/30/25 Due: 04/30/26

Perioperative Atezolizumab With MVA-BN-Brachyury and PROSTVAC For Intermediate-Risk And High-Risk Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04020094 Org: User:
Start: 11/20/19 End: 04/09/21 Due: 04/09/22

Intranasal Midazolam Versus Rectal Diazepam for Treatment of Seizures

Phase: N/A Priority: Normal
NCT ID: NCT00326612 Org: User:
Start: 06/30/06 End: 12/31/08 Due: 12/31/09

Patient Education for Patients With Back Pain Referred to Physical Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02648373 Org: User:
Start: 10/31/14 End: 10/31/15 Due: 10/31/16

Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot

Phase: N/A Priority: Normal
NCT ID: NCT01007695 Org: User:
Start: 05/31/10 End: 05/31/15 Due: 05/31/16

A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab

Phase: N/A Priority: Normal
NCT ID: NCT00123630 Org: User:
Start: 11/30/05 End: 01/31/10 Due: 01/31/11

Effects of Body Mass Index on the Hyperemic Response to Regadenoson

Phase: N/A Priority: Normal
NCT ID: NCT00859833 Org: User:
Start: 02/28/09 End: 07/31/10 Due: 07/31/11

An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death

Phase: N/A Priority: Normal
NCT ID: NCT02112084 Org: User:
Start: 05/31/10 End: 04/30/17 Due: 04/30/18

Siblings as Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT05937724 Org: User:
Start: 08/17/23 End: 11/01/23 Due: 11/01/24

Improving Palliative Care Access Through Technology

Phase: N/A Priority: Normal
NCT ID: NCT04969484 Org: User:
Start: 02/19/18 End: 06/30/22 Due: 06/30/23

Sleep Management in Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00935376 Org: User:
Start: 05/31/09 End: 07/31/10 Due: 07/31/11

Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy

Phase: N/A Priority: Normal
NCT ID: NCT05826925 Org: User:
Start: 02/27/25 End: 08/31/27 Due: 08/31/28

Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01818479 Org: User:
Start: 07/12/13 End: 04/01/19 Due: 04/01/20

Noninvasive Measurements of Renal Perfusion During Cardiac Surgery

Phase: N/A Priority: Normal
NCT ID: NCT03335865 Org: User:
Start: 03/01/18 End: 09/12/19 Due: 09/12/20

Clinical Decision Support for Blood Transfusions to Improve Guideline Adherence

Phase: N/A Priority: Normal
NCT ID: NCT05634005 Org: User:
Start: 02/01/23 End: 02/01/24 Due: 02/01/25

Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand

Phase: N/A Priority: Normal
NCT ID: NCT01549925 Org: User:
Start: 01/31/11 End: 09/30/14 Due: 09/30/15